A national prospective cohort study of COVID-19 in children referred to hospitals. All patients under the age of 18 who present to participating hospitals with suspected COVID-19 may be included. Patients with confirmed COVID-19 will be compared to patients with disproved COVID-19. We will use WHO's ISARIC model protocol, developed specifically for such pandemics. We will record epidemiological risk factors, symptoms, clinical findings, results of blood tests, X-rays and other investigations, treatment measures, complications, mortality and measures at the hospital to prevent the spread of infection. Patients are summoned for follow-up examinations 2 and 6 months after the outbreak of illness. Biological material for biobanking is taken at all time points. Patients over the age of 10 will also fill out a questionnaire on inclusion and follow-up. The questionnaire includes questions about fatigue, as well as psychosocial conditions. Data from various Norwegian patient and quality registries will be sought to strengthen the study.
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Blood Press, 31 (1), 47-49
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Hum Mol Genet, 31 (23), 3945-3966
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
Res Pract Thromb Haemost, 100002 (in press)